Dark

TRIB
Trinity Biotech plc
stock NASDAQ ADR

Market Open

Jul 22, 2026 10:02:11 AM EDT

0.2800USD-20.686%(-0.0742)857,344

0.2400Bid 0.3400Ask 0.1000Spread

Pre-market

Jul 22, 2026 9:29:30 AM EDT

0.2940USD-18.037%(-0.0647)88,158

After-hours

Jul 21, 2026 4:54:30 PM EDT

0.3516USD-2.712%(-0.0098)0

OverviewOptionsHistoricalExchangesShortsNews

Jan 28, 2022

08:21AM EST The Daily Biotech Pulse: Biogen Liquidates Out Of Biosimilar JV, Provention Bio Plots Diabetes Drug Resubmission, Merck Finds COVID Pill Effective Against Omicron Benzinga

Jan 25, 2022

08:15AM EST Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced the results of an Extraordinary General Meeting (EGM). GlobeNewswire Inc

Dec 15, 2021

06:21PM EST Trinity Biotech Announces Q3 2021 Results, the Entry Into a GlobeNewswire Inc

Oct 8, 2021

10:14AM EDT Trinity Biotech Subsidiary Biopool U.S. Wins Defense Logistic Agency Contract Worth Up To $4M Benzinga

Sep 9, 2021

09:27AM EDT Trinity Biotech Q2 EPS $0.20 Beats $0.07 Estimate, Sales $25.84M Beat $25.00M Estimate Benzinga

08:45AM EDT Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2021. GlobeNewswire Inc

08:17AM EDT The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization Benzinga

04:03AM EDT Earnings Scheduled For September 9, 2021 Benzinga

Sep 5, 2021

01:14PM EDT The Week Ahead In Biotech (Sept. 5-11): Focus On Conferences and Clinical Readouts In Another Quiet Week Benzinga

Aug 31, 2021

04:30PM EDT Trinity Biotech plc to Announce Second Quarter Fiscal Year 2021 GlobeNewswire Inc

Aug 24, 2021

03:27PM EDT Trinity Biotech Gets Australian Therapeutic Goods Administration Approval For Its Clinical Chemistry Enzyme In Vitro Diagnostics Benzinga

Jul 16, 2021

08:03AM EDT Trinity Biotech Provides A Business Development Update For Q2 2021 (Full Statement) Benzinga

08:00AM EDT Trinity Biotech plc (Nasdaq: TRIB) provides a business development update for Q2 2021. GlobeNewswire Inc

May 25, 2021

08:55AM EDT Trinity Biotech Q1 EPS $0.10 Beats $0.07 Estimate, Sales $25.60M Beat $24.00M Estimate Benzinga

08:48AM EDT Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March 31, 2021. GlobeNewswire Inc

07:53AM EDT The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal Benzinga

04:09AM EDT Earnings Scheduled For May 25, 2021 Benzinga

May 23, 2021

10:06AM EDT The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation Benzinga

May 19, 2021

12:44PM EDT Trinity Biotech plc to Announce First Quarter Fiscal Year 2021 GlobeNewswire Inc

May 3, 2021

09:49AM EDT Overview Of Value Stocks In The Healthcare Sector Benzinga

Mar 30, 2021

09:04AM EDT Trinity Biotech Announces The Submission Of TrinScreen HIV To The WHO For Approval Benzinga

09:00AM EDT Trinity Biotech plc (Nasdaq: TRIB) has submitted its new HIV screening product, TrinScreen HIV, to the World Health Organisation (WHO) for approval. GlobeNewswire Inc

Mar 25, 2021

09:31AM EDT Trinity Biotech Q4 EPS $0.36 Beats $0.14 Estimate, Sales $32.77M Beat $28.00M Estimate Benzinga

09:28AM EDT Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended December 31, 2020 and fiscal year 2020. GlobeNewswire Inc

Mar 23, 2021

04:15PM EDT Trinity Biotech plc to Announce Fourth Quarter and Fiscal Year GlobeNewswire Inc

Feb 9, 2021

08:10AM EST The Daily Biotech Pulse: Dynavax Poaches GSK Vaccine Exec, KalVista Jumps On Data Readout, Corcept Issues Negative Preannouncement Benzinga

Jan 29, 2021

12:57PM EST Trinity Biotech Resumes For Trade Up 23% For The Session Benzinga

12:54PM EST Trinity Biotech Shares Are Halted On A Circuit Breaker; Shares Up 22% For Session Benzinga

12:53PM EST Trinity Biotech Shares Are Halted On A Circuit Braker Benzinga

Jan 5, 2021

10:34AM EST Shares of Trinity Biotech plc (TRIB) are currently gaining over 15% after the company said it has achieved CE Mark approval and registration for its Covid-19 IgG ELISA antibody test, the Captia SARS-CoV-2 IgG ELISA. RTTNews

08:20AM EST Benzinga Pro's Top 5 Stocks To Watch For Tuesday, Jan. 5, 2021: MU, KTOS, NAKD, TRIB, CHEK Benzinga

08:05AM EST Trinity Biotech Announces CE Mark Of Its Covid-19 IgG ELISA Antibody Test Benzinga

08:04AM EST Trinity Biotech plc (Nasdaq: TRIB) has achieved CE Mark approval and registration for its Covid-19 IgG ELISA antibody test, the Captia SARS-CoV-2 IgG ELISA. GlobeNewswire Inc

Dec 1, 2020

08:08AM EST The Daily Biotech Pulse: Pfizer, BioNTech File Marketing Application In Europe, NuCana Jumps On Data, Amarin Takes On Hikma In Patent Lawsuit Benzinga

Nov 25, 2020

07:35AM EST The Daily Biotech Pulse: Revance's DAXI Regulatory Decision, Reata Slips On FDA Feedback, Liquidia Setback Benzinga

Nov 24, 2020

08:13AM EST The Daily Biotech Pulse: Alnylam's Oxluma Snags Early FDA Approval, DBV Chief Scientific Officer To Depart, Decision Day For Liquidia Benzinga

Nov 18, 2020

07:30AM EST The Daily Biotech Pulse: Kazia Jumps On Data Readout, Clinical Hold On Cellectis' Blood Cancer Study Lifted Benzinga

Nov 17, 2020

12:21PM EST Trinity Biotech shares were trading higher after the company reported Q3 EPS results up from last year and better-than-expected Q3 sales results. Benzinga

09:13AM EST Trinity Biotech Q3 EPS $0.32 Up From $0.04 YoY, Sales $32.00M Beat $21.18M Estimate Benzinga

09:12AM EST Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended September 30, 2020. GlobeNewswire Inc

08:32AM EST The Daily Biotech Pulse: Setback For Alkermes, Boston Scientific's Recall, ALX-Zymeworks Oncology Collaboration Benzinga

04:07AM EST Earnings Scheduled For November 17, 2020 Benzinga

Nov 16, 2020

10:02AM EST 68 Stocks Trading Near 52-Week Highs Just After Open On Monday, Nov. 16, 2020: Benzinga

Sep 8, 2020

03:57PM EDT Trinity Biotech Shares Move Higher; Hearing Co Receives Emergency Use Authorization On Antibody Test Benzinga

Aug 25, 2020

09:54AM EDT Trinity Biotech Q2 Total Revenues $16.0 Mln Vs $22.5 Mln Last Year RTTNews

09:45AM EDT Trinity Biotech Q2 EPS $(0.04) Down From $(0.00) YoY, Sales $16.02M Miss $21.18M Estimate Benzinga

09:41AM EDT Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended June 30, 2020. GlobeNewswire Inc

04:22AM EDT Earnings Scheduled For August 25, 2020 Benzinga

Aug 20, 2020

12:36PM EDT Trinity Biotech shares are trading higher after the company announced a EUA submission for coronavirus ELISA antibody test. Benzinga

11:17AM EDT Trinity Biotech Reports EUA Submission For Covid-19 ELISA Antibody Test RTTNews

10:33AM EDT Trinity Biotech Announces EUA Submission For Coronavirus ELISA Antibody Test Benzinga

10:31AM EDT Trinity Biotech announces EUA submission for Covid-19 ELISA GlobeNewswire Inc

Aug 18, 2020

08:04AM EDT Trinity Biotech plc to Announce Second Quarter 2020 Financial Results GlobeNewswire Inc

Aug 17, 2020

09:25AM EDT Trinity Biotech Subsidiary, Primus Corporation Secures FDA Warning Letter RTTNews

09:14AM EDT Trinity Biotech Subsidiary, Primus Corporation Receives FDA Warning Letter Following An Inspection Of Kansas City Manufacturing Facility That Took Place In January 2020 Benzinga

09:10AM EDT Trinity Biotech subsidiary, Primus Corporation Receives FDA GlobeNewswire Inc